CHINA HEALTH GRP HD-10 Cash Flow Reinvestment Rate
CHINA HEALTH GRP HD-10 cash flow reinvestment rate. CHINA HEALTH GRP HD-10 (VNL1) has a Cash Flow Reinvestment Rate of 0.31x as of December 2024, reinvesting €3.23 Million (capex €1.76 Million plus investments €1.47 Million) from operating cash flow of €10.28 Million. Explore VNL1 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of CHINA HEALTH GRP HD-10 (2023–2024)
Cash flow reinvestment rate of CHINA HEALTH GRP HD-10 from 2023 to 2024. Historical reinvestment intensity for CHINA HEALTH GRP HD-10 across 2 annual periods. Explore CHINA HEALTH GRP HD-10 (VNL1) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
CHINA HEALTH GRP HD-10 Cash Flow Reinvestment Rate by Year (2023–2024)
CHINA HEALTH GRP HD-10 cash flow reinvestment rate by year from 2023 to 2024. Year-by-year capital reinvestment analysis for CHINA HEALTH GRP HD-10. For the full cash flow conversion analysis, see cash efficiency ratio of CHINA HEALTH GRP HD-10.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.31x | €3.23 Million | €10.28 Million | €1.76 Million | ▼ -96.8% |
| 2023 | 9.68x | €10.85 Million | €1.12 Million | €6.00 Million | — |